Osteoporosis management in hematologic stem cell transplant recipients: Executive summary

Area of Science:

• Hematology
• Oncology
• Bone Metabolism

Background:

• Advances in hematopoietic stem cell transplant (HSCT) have improved survival rates.
• Long-term survivors of HSCT experience increased concerns regarding bone health.
• Bone fragility and fracture are significant long-term morbidities following HSCT.

Purpose of the Study:

• To summarize key recommendations for managing bone health in HSCT recipients.
• To provide guidance on bone assessment, lifestyle modifications, and pharmacotherapy.
• To address the growing need for long-term care strategies in HSCT survivors.

Main Methods:

• Review and synthesis of previously published recommendations.
• Focus on bone assessment strategies.
• Inclusion of dietary, lifestyle, and medication management guidelines.

Main Results:

• Evidence supports enhanced monitoring of bone fragility in HSCT recipients.
• Recommendations include appropriate administration of osteoporosis pharmacotherapies.
• Guidelines address patients at high risk for bone loss and fracture.

Conclusions:

• This executive summary consolidates critical recommendations for HSCT patients.
• Management strategies encompass bone assessment, lifestyle advice, and medication.
• Proactive bone health management is essential for long-term HSCT survivor outcomes.